New Jersey-based Eagle Pharmaceuticals, Inc. has reached agreement on the terms to acquire Acacia Pharma Group plc. The terms of the proposed transaction value Acacia Pharma’s existing issued and to be issued share capital at approximately €94,700,000. The terms of the proposed transaction also provide for Eagle to guarantee approximately €25.0 million of debt within the Acacia Pharma group.  The proposed transaction has been approved by the boards of directors of both companies and is expect...